Genmab
GMAB
GMAB
219 hedge funds and large institutions have $1.23B invested in Genmab in 2024 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 69 increasing their positions, 93 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
26% less repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 93
74% less call options, than puts
Call options by funds: $178K | Put options by funds: $696K
Holders
219
Holding in Top 10
–
Calls
$178K
Puts
$696K
Top Buyers
| 1 | +$30.7M | |
| 2 | +$11.5M | |
| 3 | +$8.86M | |
| 4 |
Two Sigma Advisers
New York
|
+$6.96M |
| 5 |
Goldman Sachs
New York
|
+$5.59M |
Top Sellers
| 1 | -$13.3M | |
| 2 | -$7.57M | |
| 3 | -$7.25M | |
| 4 |
Royal London Asset Management
United Kingdom
|
-$4.41M |
| 5 |
Capital International Investors
Los Angeles,
California
|
-$3.72M |